+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Vascular Endothelial Growth Factor Receptor 3 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Endothelial Growth Factor Receptor 3 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Adenosine Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025 - Product Thumbnail Image

Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cushing Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cushing Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Complement Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Polycystic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Polycystic Kidney Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Recurrent Clostridioides Difficile Infection (rCDI) - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Clostridioides Difficile Infection (rCDI) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Intracranial Arterial Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Intracranial Arterial Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Irritable Bowel Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Irritable Bowel Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Juvenile Idiopathic Arthritis (JIA) - Pipeline Insight, 2025 - Product Thumbnail Image

Juvenile Idiopathic Arthritis (JIA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Juvenile Macular Degeneration - Pipeline Insight, 2025 - Product Thumbnail Image

Juvenile Macular Degeneration - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Kawasaki Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Kawasaki Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
KCNQ2 Developmental And Epileptic Encephalopathy (KCNQ2-DEE) - Pipeline Insight, 2025 - Product Thumbnail Image

KCNQ2 Developmental And Epileptic Encephalopathy (KCNQ2-DEE) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Laron Syndrome (LS) - Pipeline Insight, 2025 - Product Thumbnail Image

Laron Syndrome (LS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Late-stage Chronic Kidney Disease (CKD) - Pipeline Insight, 2025 - Product Thumbnail Image

Late-stage Chronic Kidney Disease (CKD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leigh Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Leigh Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lennox Gastaut Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Lennox Gastaut Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Levodopa-Induced Dyskinesia (LID) - Pipeline Insight, 2025 - Product Thumbnail Image

Levodopa-Induced Dyskinesia (LID) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more